Prevalence

An estimate of the number of people in Italy living after a childhood cancer
Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe
Cancer cost profiles: The Epicost estimation approach
Cancer prevalence by phase of care: an indicator for assessing health service needs
Characteristics of people living in Italy after a cancer diagnosis in 2010 and projections to 2020
Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study
Complete prevalence and indicators of cancer cure: enhanced methods and validation in Italian population-based cancer registries
Cure indicators and prevalence by stage at diagnosis for breast and colorectal cancer patients: A population-based study in Italy
Embryonal cancers in Europe
Epidemiology of glial and non-glial brain tumours in Europe
Epidemiology of rare cancers and inequalities in oncologic outcomes
Estimating complete cancer prevalence in Europe: validity of alternative vs standard completeness indexes
Incidence and survival of rare urogenital cancers in Europe
Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002
Italian cancer figures - Report 2015: The burden of rare cancers in Italy
Italy 2015: 3 million Italians are living after a cancer diagnosis, both incidence and mortality are decreasing
Methodological aspects of estimating rare cancer prevalence in Europe: the experience of the RARECARE project
Patients with cancer who will be cured and projections of complete prevalence in Italy from 2018 to 2030
Projecting cancer prevalence by phase of care: a methodological approach for health service planning
Rare cancers are not so rare: the rare cancer burden in Europe

Page 1 of 2

Start
Prev
1
2
Next
End

This website uses cookies to ensure you get the best experience. Learn more about it.